These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21515732

  • 1. Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222.
    Jacobson MJ, Lin G, Tepp W, Dupuy J, Stenmark P, Stevens RC, Johnson EA.
    Appl Environ Microbiol; 2011 Jun; 77(12):4217-22. PubMed ID: 21515732
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
    Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.
    PLoS One; 2015 Jun; 10(2):e0116381. PubMed ID: 25658638
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
    Zhao H, Nakamura K, Kohda T, Mukamoto M, Kozaki S.
    Jpn J Infect Dis; 2012 Jun; 65(2):138-45. PubMed ID: 22446121
    [Abstract] [Full Text] [Related]

  • 8. Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype.
    Raphael BH, Lautenschlager M, Kalb SR, de Jong LI, Frace M, Lúquez C, Barr JR, Fernández RA, Maslanka SE.
    BMC Microbiol; 2012 Oct 31; 12():245. PubMed ID: 23113872
    [Abstract] [Full Text] [Related]

  • 9. Neurotoxin gene clusters in Clostridium botulinum type Ab strains.
    Lúquez C, Raphael BH, Maslanka SE.
    Appl Environ Microbiol; 2009 Oct 31; 75(19):6094-101. PubMed ID: 19684172
    [Abstract] [Full Text] [Related]

  • 10. Development of an Equine Antitoxin by Immunizing the Halla Horse with the Receptor-Binding Domain of Botulinum Neurotoxin Type A1.
    Kim NY, Park KE, Lee YJ, Kim YM, Hong SH, Son WR, Hong S, Lee S, Ahn HB, Yang J, Seo JP, Lim YK, Yu CH, Hur GH, Jeong ST, Lee HS, Song K, Kang TJ, Shin YK, Choi JS, Choi JY.
    J Microbiol Biotechnol; 2019 Jul 28; 29(7):1165-1176. PubMed ID: 31280529
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT.
    Infect Immun; 2005 Oct 28; 73(10):6998-7005. PubMed ID: 16177380
    [Abstract] [Full Text] [Related]

  • 13. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
    Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD.
    Infect Immun; 2005 Sep 28; 73(9):5450-7. PubMed ID: 16113261
    [Abstract] [Full Text] [Related]

  • 14. Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.
    Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S.
    J Clin Microbiol; 2009 Sep 28; 47(9):2720-8. PubMed ID: 19571018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.